Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan:174:47-55.
doi: 10.1016/j.yjmcc.2022.11.003. Epub 2022 Nov 21.

Mitochondrial permeability transition pore-dependent necrosis

Affiliations
Review

Mitochondrial permeability transition pore-dependent necrosis

Dexter J Robichaux et al. J Mol Cell Cardiol. 2023 Jan.

Abstract

Mitochondrial permeability transition pore (mPTP)-dependent cell death is a form of necrotic cell death that is driven by mitochondrial dysfunction by the opening of the mPTP and is triggered by increases in matrix levels of Ca2+ and reactive oxygen species. This form of cell death has been implicated in ischemic injuries of the heart and brain as well as numerous degenerative diseases in the brain and skeletal muscle. This review focuses on the molecular triggers and regulators of mPTP-dependent necrosis in the context of myocardial ischemia reperfusion injury. Research over the past 50 years has led to the identity of regulators and putative pore-forming components of the mPTP. Finally, downstream consequences of activation of the mPTP as well as ongoing questions and areas of research are discussed. These questions pose a particular interest as targeting the mPTP could potentially represent an efficacious therapeutic strategy to reduce infarct size following an ischemic event.

Keywords: ANT; ATP synthase; BAK; BAX; Calcium; CypD; Ischemia reperfusion; MPTP; Mitochondria; Mitochondrial dysfunction; Necrosis; Permeability transition; ROS.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Outstanding questions surrounding the regulation, identity, and pathological relevance of the mPTP.
Schematic representation of the current model of the mPTP, its regulators and its triggers. Though it is known that Ca2+ and ROS trigger the mPTP, and various protein components of the mPTP have been proposed, there are essential questions that remain to be addressed: ① How does Ca2+ trigger mPTP? ② How does ROS sensitize mPTP to Ca2+? ③ What is the target of CypD activity? ④ Is ANT a regulator or pore forming component of mPTP? ⑤ Is ATP synthase a regulator or pore forming component of mPTP? ⑥ How does outer mitochondrial membrane permeability influence matrix calcium retention capacity? ⑦ Are contact sites essential for mPTP activity? ⑧ Is the mPTP composed of two pore forming entities (ANT and ATP synthase pores)? ⑨ Are there additional pore forming components of the mPTP? ⑩ Can complete inhibition of mPTP protect humans against myocardial infarct injury?
Figure 2:
Figure 2:. mPTP dependent mitochondrial dysfunction can potentially feed into other cell death pathways.
Following mPTP opening, mitochondrial membrane potential and eventually integrity decreases. This leads to a decrease in mitochondrial ATP production, which can lead to an increase in glycolysis as a compensatory mechanism to maintain the energetic demand of the cell. These events culminate in the reduction of the NAD+ pools which can sensitize a cell to parthanatos. Energetic depletion may also result in the over activation of autophagy, which may result in autophagic or lysosomal dependent cell death. In addition, mitochondrial membrane rupture can trigger other cell death modalities. For example, rupture can lead to Cytochrome C (Cyt C) release, which may initiate apoptosis or mtDNA release, which can initiate pyroptosis.

References

    1. Haworth RA, Hunter DR, The Ca2+-induced membrane transition in mitochondria, Arch Biochem Biophys. 195 (1979) 460–467. 10.1016/0003-9861(79)90372-2. - DOI - PubMed
    1. Halestrap AP, What is the mitochondrial permeability transition pore?, J Mol Cell Cardiol. 46 (2009) 821–831. 10.1016/j.yjmcc.2009.02.021. - DOI - PubMed
    1. Skyschally A, Schulz R, Heusch G, Cyclosporine A at Reperfusion Reduces Infarct Size in Pigs, Cardiovasc Drugs Ther. 24 (2010) 85–87. 10.1007/s10557-010-6219-y. - DOI - PMC - PubMed
    1. Argaud L, Gateau O, Muntean D, Chalabreysse L, Loufouat J, Robert D, Ovize M, Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury, J Mol Cell Cardiol. 38 (2005) 367–374. 10.1016/j.yjmcc.2004.12.001. - DOI - PubMed
    1. Zhang C, Cheng Y, Liu D, Liu M, Cui H, Zhang B, Mei Q, Zhou S, Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats, J Nanobiotechnology. 17 (2019) 18. 10.1186/s12951-019-0451-9. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances